Patient-reported adverse events under asthma therapy: A community pharmacy-based survey

被引:4
作者
Laforest, L.
Van Ganse, E. [1 ]
Devouassoux, G.
Osman, L. M.
Bauguil, G.
Chamba, G.
机构
[1] Univ Lyon 1, Fac Pharm, F-69365 Lyon, France
[2] Univ Lyon 1, Fac Med, Unite Pharmacoepidemiol, Oullins, France
[3] CHU Lyon, Resp Med, Lyon, France
[4] Univ Aberdeen, Dept Med & Therapeut, Aberdeen AB9 1FX, Scotland
[5] Pharmakeion, Lyon, France
关键词
D O I
10.1038/sj.clpt.6100224
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The characteristics of patients who report adverse events (AEs) attributed to asthma therapy have been little investigated. Asthma patients aged 18-50 years were surveyed in pharmacies. Patients completed a questionnaire linked to computerized records of dispensed medications. Patients reported all AEs that they attributed to asthma therapy. The correlates of reporting 2+ AEs were identified. Almost 59% of the 1,351 patients (mean age: 37, 56% females) attributed AEs to asthma therapy, and 35% at least two. Most common AEs included tiredness (21.8%) and palpitations (21.1%). Poor asthma control and perception of asthma as a handicap were the major correlates of reporting 2+ AEs (odds ratio (OR) = 2.5, 95% confidence interval (CI) =[1.7-3.7] and OR = 1.9, 95% CI =[1.4-2.5]). Other significant correlates included age 430 years, female gender, and receiving psychotropic therapy. Inadequate control may partly account for AEs attributed by patients to asthma therapy. Improving patients' education may help to improve acceptability of asthma therapy.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 18 条
[1]  
BOSLEY CM, 1995, EUR RESPIR J, V8, P899
[2]   Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients [J].
Boulet, LP .
CHEST, 1998, 113 (03) :587-592
[3]   Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices [J].
Chambers, CV ;
Markson, L ;
Diamond, JJ ;
Lasch, L ;
Berger, M .
RESPIRATORY MEDICINE, 1999, 93 (02) :88-94
[4]   Self-reported adherence in patients with asthma [J].
De Smet, BD ;
Erickson, SR ;
Kirking, DM .
ANNALS OF PHARMACOTHERAPY, 2006, 40 (03) :414-420
[5]   Steroid inhaler laryngitis - Dysphonia caused by inhaled fluticasone therapy [J].
DelGaudio, JM .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (06) :677-681
[6]   Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: A cross-sectional analysis [J].
Foster, Juliet M. ;
Aucott, Lorna ;
van der Werf, Rik H. W. ;
van der Meijden, Mariken J. ;
Schraa, Gysbert ;
Postma, Dirkje S. ;
van der Molen, Thys .
RESPIRATORY MEDICINE, 2006, 100 (08) :1318-1336
[7]  
Gibson PG., 2003, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD001117
[8]   Managing asthma in the real world [J].
Gillissen, A .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (06) :592-603
[9]   Corticosteroid use after hospital discharge among high-risk adults with asthma [J].
Krishnan, JA ;
Riekert, KA ;
McCoy, JV ;
Stewart, DY ;
Schmidt, S ;
Chanmugam, A ;
Hill, P ;
Rand, CS .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (12) :1281-1285
[10]   Quality of asthma care: results from a community pharmacy based survey [J].
Laforest, L ;
Van Ganse, E ;
Devouassoux, G ;
Chretin, S ;
Bauguil, G ;
Pacheco, Y ;
Chamba, G .
ALLERGY, 2005, 60 (12) :1505-1510